NCT02718118 - Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Glabellar LinesWrinkles

Interventions

DEVICE

Dysport reconstituted at 1.5 mL (0.05 mL/injection)

Subjects treated for moderate to severe (GLSS = 2 or 3) glabellar lines at maximum frown.

DEVICE

Dysport reconstituted at 2.5 mL (0.08 mL/injection)

Subjects treated for moderate to severe (GLSS = 2 or 3) glabellar lines at maximum frown.

Trial Locations (3)

AboutSkin Dermatology and DermSurgery, Greenwood Village

Skin Research Institute, Coral Gables

Marina Peredo, MD, PC, Smithtown